Ledger. Australian venture funding, tracked

Company

PATH

Coverage

Stories naming PATH. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Funding announcement

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

Vaxxas reports positive Phase I results for its needle-free skin-patch delivery of a measles-rubella vaccine, with Gates Foundation grant funding and a planned PATH-sponsored Phase I/II trial in The Gambia.

Brandon BioCatalyst portfolio 26 Nov 2023 Bill & Melinda Gates FoundationBiomedical Advanced Research and Development AuthorityBrandon BioCatalystBrandon CapitalHealthcare VenturesOneVenturesOneVentures Innovation Fund IPATHThe University of QueenslandThe University of SydneyThe Yates NetworkUniQuestUniversity of OtagoUniversity of the Sunshine CoastVaxxasWE CommunicationAustralian GovernmentAmy MillerDr David L HoeyKathryn Morris
17 deals

The Week in Agrifoodtech: The Rounds bags $38m for waste-free e-grocery, Jay-Z invests in pizza robot startup Stellar

Weekly roundup of agrifoodtech venture raises across food and agtech, plus JBS shutting its Planterra alt-protein division and Australian startup Optomni's seed round.

AgFunderNews 6 Oct 2022 EQUIIFoodsiGourmeyInariLiquid DeathOptomniPATHAmazonBlueNaluDeliverooGoPuffGrubhubJBSMorrisonsNational University of SingaporeNestléQuantum Energy PartnersUniversity of Southern CaliforniaVowAltos VenturesAndreessen HorowitzBuilders VCCanada Pension Plan Investment BoardEarlybirdKhosla VenturesLive NationSkalata VenturesVelocity Ventures

Something wrong? Tell us